Literature DB >> 23400808

Impaired GABAergic neurotransmission in schizophrenia underlies impairments in cortical gamma band oscillations.

James M McNally1, Robert W McCarley, Ritchie E Brown.   

Abstract

Impairment of cortical circuit function is increasingly believed to be central to the pathophysiology of schizophrenia (Sz). Such impairments are suggested to result in abnormal gamma band oscillatory activity observed in Sz patients, and likely underlie the psychosis and cognitive deficits linked to this disease. Development of improved therapeutic strategies to enhance functional outcome of Sz patients is contingent upon a detailed understanding of the mechanisms behind cortical circuit development and maintenance. Convergent evidence from both Sz clinical and preclinical studies suggests impaired activity of a particular subclass of interneuron which expresses the calcium binding protein parvalbumin is central to the cortical circuit impairment observed. Here we review our current understanding of the Sz related cortical circuit dysfunction with a particular focus on the role of fast spiking parvalbumin interneurons in both normal cortical circuit activity and in NMDA receptor hypofunction models of the Sz disease state.

Entities:  

Mesh:

Year:  2013        PMID: 23400808      PMCID: PMC3595504          DOI: 10.1007/s11920-012-0346-z

Source DB:  PubMed          Journal:  Curr Psychiatry Rep        ISSN: 1523-3812            Impact factor:   5.285


  99 in total

1.  Short-term and long-term effects of N-methyl-D-aspartate receptor hypofunction.

Authors:  R Greene; R Bergeron; R McCarley; J T Coyle; H Grunze
Journal:  Arch Gen Psychiatry       Date:  2000-12

2.  First in vivo evidence of an NMDA receptor deficit in medication-free schizophrenic patients.

Authors:  L S Pilowsky; R A Bressan; J M Stone; K Erlandsson; R S Mulligan; J H Krystal; P J Ell
Journal:  Mol Psychiatry       Date:  2006-02       Impact factor: 15.992

Review 3.  Synaptic mechanisms of synchronized gamma oscillations in inhibitory interneuron networks.

Authors:  Marlene Bartos; Imre Vida; Peter Jonas
Journal:  Nat Rev Neurosci       Date:  2007-01       Impact factor: 34.870

Review 4.  Neural synchrony in brain disorders: relevance for cognitive dysfunctions and pathophysiology.

Authors:  Peter J Uhlhaas; Wolf Singer
Journal:  Neuron       Date:  2006-10-05       Impact factor: 17.173

5.  NMDA-dependent modulation of CA1 local circuit inhibition.

Authors:  H C Grunze; D G Rainnie; M E Hasselmo; E Barkai; E F Hearn; R W McCarley; R W Greene
Journal:  J Neurosci       Date:  1996-03-15       Impact factor: 6.167

6.  Association of ketamine-induced psychosis with focal activation of the prefrontal cortex in healthy volunteers.

Authors:  A Breier; A K Malhotra; D A Pinals; N I Weisenfeld; D Pickar
Journal:  Am J Psychiatry       Date:  1997-06       Impact factor: 18.112

7.  Gamma oscillation deficits and the onset and early progression of schizophrenia.

Authors:  Tsung-Ung W Woo; Kevin Spencer; Robert W McCarley
Journal:  Harv Rev Psychiatry       Date:  2010 May-Jun       Impact factor: 3.732

Review 8.  GABA neurons and the mechanisms of network oscillations: implications for understanding cortical dysfunction in schizophrenia.

Authors:  Guillermo Gonzalez-Burgos; David A Lewis
Journal:  Schizophr Bull       Date:  2008-06-26       Impact factor: 9.306

9.  Ketamine increases human motor cortex excitability to transcranial magnetic stimulation.

Authors:  V Di Lazzaro; A Oliviero; P Profice; M A Pennisi; F Pilato; G Zito; M Dileone; R Nicoletti; P Pasqualetti; P A Tonali
Journal:  J Physiol       Date:  2003-01-17       Impact factor: 5.182

10.  Baseline gamma power during auditory steady-state stimulation in schizophrenia.

Authors:  Kevin M Spencer
Journal:  Front Hum Neurosci       Date:  2012-01-13       Impact factor: 3.169

View more
  20 in total

1.  Cortical parvalbumin GABAergic deficits with α7 nicotinic acetylcholine receptor deletion: implications for schizophrenia.

Authors:  Hong Lin; Fu-Chun Hsu; Bailey H Baumann; Douglas A Coulter; Stewart A Anderson; David R Lynch
Journal:  Mol Cell Neurosci       Date:  2014-06-28       Impact factor: 4.314

Review 2.  Targeting Oxidative Stress and Aberrant Critical Period Plasticity in the Developmental Trajectory to Schizophrenia.

Authors:  Kim Q Do; Michel Cuenod; Takao K Hensch
Journal:  Schizophr Bull       Date:  2015-06-01       Impact factor: 9.306

3.  Cortically projecting basal forebrain parvalbumin neurons regulate cortical gamma band oscillations.

Authors:  Tae Kim; Stephen Thankachan; James T McKenna; James M McNally; Chun Yang; Jee Hyun Choi; Lichao Chen; Bernat Kocsis; Karl Deisseroth; Robert E Strecker; Radhika Basheer; Ritchie E Brown; Robert W McCarley
Journal:  Proc Natl Acad Sci U S A       Date:  2015-03-02       Impact factor: 11.205

Review 4.  Gamma band oscillations: a key to understanding schizophrenia symptoms and neural circuit abnormalities.

Authors:  James M McNally; Robert W McCarley
Journal:  Curr Opin Psychiatry       Date:  2016-05       Impact factor: 4.741

5.  Parvalbumin-containing GABA cells and schizophrenia: experimental model based on targeted gene delivery through adeno-associated viruses.

Authors:  Marta U Woloszynowska-Fraser; Peer Wulff; Gernot Riedel
Journal:  Behav Pharmacol       Date:  2017-12       Impact factor: 2.293

6.  Consequences of acute Nav1.1 exposure to deltamethrin.

Authors:  T F James; Miroslav N Nenov; Cynthia M Tapia; Marzia Lecchi; Shyny Koshy; Thomas A Green; Fernanda Laezza
Journal:  Neurotoxicology       Date:  2016-12-19       Impact factor: 4.294

7.  Evaluating delay of gamma oscillations in patients with schizophrenia using evoked response audiometry system.

Authors:  Masaya Yanagi; Aki Tsuchiya; Fumiharu Hosomi; Toru Terada; Satoshi Ozaki; Osamu Shirakawa; Mamoru Hashimoto
Journal:  Sci Rep       Date:  2022-07-05       Impact factor: 4.996

Review 8.  History of the Concept of Disconnectivity in Schizophrenia.

Authors:  Joseph T Coyle; Darrick T Balu; Matthew D Puhl; Glenn T Konopaske
Journal:  Harv Rev Psychiatry       Date:  2016 Mar-Apr       Impact factor: 3.732

Review 9.  Redox dysregulation, neuroinflammation, and NMDA receptor hypofunction: A "central hub" in schizophrenia pathophysiology?

Authors:  P Steullet; J H Cabungcal; A Monin; D Dwir; P O'Donnell; M Cuenod; K Q Do
Journal:  Schizophr Res       Date:  2014-07-05       Impact factor: 4.939

10.  LPA signaling initiates schizophrenia-like brain and behavioral changes in a mouse model of prenatal brain hemorrhage.

Authors:  H Mirendil; E A Thomas; C De Loera; K Okada; Y Inomata; J Chun
Journal:  Transl Psychiatry       Date:  2015-04-07       Impact factor: 6.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.